RC
| |
RA CAPITAL MANAGEMENT, L.P.13F | |
RA CAPITAL MANAGEMENT, L.P. | |
Last update 2024-11-15 | 81 Stocks (9 new) |
Value $8.67 Bil | Turnover 8 % |
Portfolio Report |
RA CAPITAL MANAGEMENT, L.P. Top Holdings of 2024-09-30
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ASND | Ascendis Pharma AS | 9,710,428 | 1449864.010 | -3.94% | 16.720 | -0.72% | 16.250 | +5.43% | -2.51% | 8095.880 | Biotechnology | |
PCVX | Vaxcyte Inc | 8,689,190 | 992913.740 | +5.92% | 11.450 | +0.64% | 6.970 | -28.46% | +0.93% | 10457.006 | Biotechnology | |
JANX | Janux Therapeutics Inc | 9,165,652 | 416395.570 | 0% | 4.800 | 0% | 17.470 | -11.45% | -12.78% | 2710.594 | Biotechnology | |
LEGN | Legend Biotech Corp | 7,506,934 | 365812.890 | 0% | 4.220 | 0% | 4.070 | -29.64% | -2.89% | 5907.106 | Biotechnology | |
RYTM | Rhythm Pharmaceuticals Inc | 6,084,412 | 318762.350 | 0% | 3.680 | 0% | 9.900 | +7.65% | -3.06% | 3345.107 | Biotechnology | |
RNA | Avidity Biosciences Inc | 6,300,408 | 289377.740 | +16.67% | 3.340 | +0.48% | 5.280 | -38.97% | -1.99% | 3344.241 | Biotechnology | |
TYRA | Tyra Biosciences Inc | 10,416,609 | 244894.480 | 0% | 2.820 | 0% | 20.590 | -32.99% | +17.91% | 862.022 | Biotechnology | |
EVH | Evolent Health Inc | 8,514,862 | 240800.300 | 0% | 2.780 | 0% | 7.400 | -57.60% | -0.53% | 1256.087 | Healthcare Providers & Services | |
EWTX | Edgewise Therapeutics Inc | 8,909,091 | 237783.640 | 0% | 2.740 | 0% | 9.410 | -12.66% | +7.92% | 2830.239 | Biotechnology | |
BIIB | Biogen Inc | 1,184,456 | 229594.950 | +20.60% | 2.650 | +0.45% | 0.810 | -24.10% | -4.93% | 20960.268 | Drug Manufacturers |
RA CAPITAL MANAGEMENT, L.P.'s Historical Top Holdings Breakdowns
RA CAPITAL MANAGEMENT, L.P.'s Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
IMGN | Immunogen Inc | 2024-03-31 | Sold Out | -11.00% | 29.26 ($29.77) 31.23 | $31.23 | 4.90% | Sold Out | 0 | -23,750,601 | |
ASND | Ascendis Pharma A/S | 2023-06-30 | Add | +7.19% | 69.96 ($87.35) 107.22 | $135.36 | 54.96% | Add 61.35% | 11,225,357 | 4,268,178 | |
DICE | DICE Therapeutics Inc | 2023-09-30 | Sold Out | -6.89% | 46.4 ($47.05) 47.55 | $47.55 | 1.06% | Sold Out | 0 | -7,856,612 | |
LEGN | Legend Biotech Corp | 2023-06-30 | Add | +4.99% | 46.28 ($65.07) 75.01 | $32.20 | -50.51% | Add 157.15% | 6,264,707 | 3,828,484 | |
IMGN | Immunogen Inc | 2023-12-31 | Add | +4.83% | 12.46 ($19.91) 29.95 | $31.23 | 56.86% | Add 78.28% | 23,750,601 | 10,428,313 | |
IMGN | Immunogen Inc | 2023-09-30 | Add | +3.43% | 14.09 ($16.63) 19.87 | $31.23 | 87.79% | Add 471.78% | 13,322,288 | 10,992,330 | |
CBAY | CymaBay Therapeutics Inc | 2024-03-31 | Sold Out | -2.56% | 22.46 ($28.19) 32.48 | $32.48 | 15.22% | Sold Out | 0 | -6,940,000 | |
EWTX | Edgewise Therapeutics Inc | 2024-03-31 | New Buy | +2.07% | 9.25 ($15.89) 19.97 | $29.89 | 88.11% | New holding | 8,909,091 | 8,909,091 | |
BLU | BELLUS Health Inc | 2023-06-30 | Sold Out | -2.06% | 6.46 ($13.23) 14.75 | $14.74 | 11.41% | Sold Out | 0 | -12,643,574 | |
BCAX | Bicara Therapeutics Inc | 2024-09-30 | New Buy | +2.04% | 23.41 ($25.5) 27.07 | $13.50 | -47.07% | New holding | 6,955,993 | 6,955,993 |
RA CAPITAL MANAGEMENT, L.P. Total Holding History ($B)
RA CAPITAL MANAGEMENT, L.P.'s Asset Allocation
RA CAPITAL MANAGEMENT, L.P. Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
RA CAPITAL MANAGEMENT, L.P.'s Hypothetical Growth since 2024-09-30
RA CAPITAL MANAGEMENT, L.P.'s Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
RA CAPITAL MANAGEMENT, L.P.'s Holdings Heat Map
Size field:
RA CAPITAL MANAGEMENT, L.P.'s Holdings Bubble Chart
RA CAPITAL MANAGEMENT, L.P. News
- 1